Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sarepta Therapeutics (SRPT) Q4 2024 Earnings Call Transcript


Image source: The Motley Fool.

Sarepta Therapeutics (NASDAQ: SRPT)
Q4 2024 Earnings Call
Feb 26, 2025, 4:30 p.m. ET

Operator

Continue reading


Source Fool.com

Sarepta Therapeutics Stock

€16.68
7.230%
Sarepta Therapeutics dominated the market today, gaining €1.13 (7.230%).
Currently there is a rather positive sentiment for Sarepta Therapeutics with 4 Buy predictions and 0 Sell predictions.
Based on the current price of 16.68 € the target price of 135 € shows a potential of 709.6% for Sarepta Therapeutics which would more than double the current price.
Like: 0
Share

Comments